Analysis of circulating tumor cells (CTCs) as a tool for monitoring metastatic cancers, early diagnosis, and evaluation of disease prognosis paves the way toward personalized cancer treatment.

Breast cancer early detection is crucial for improving patient outcomes. The Institut Catala de la Salut (ICS) has launched‘ the DigiPatICS project to develop and implement artificial intelligence ...

The European Commission (EC) has granted conditional approval to Jazz Pharmaceuticals’ Ziihera (zanidatamab) to treat a ...